Sriram Ryali Eiger Bio Pharmaceuticals, Inc. (EIGR) insider trading activity

EIGR Quotes by TradingView

Sriram Ryali is Chief Financial Officer of Eiger BioPharmaceuticals, Inc.. Currently has a direct ownership of 41,566 shares of EIGR, which is worth approximately $525,809. The most recent transaction as insider was on Mar 14, 2022, when has been sold 2,266 shares (Common Stock) at a price of $5.6 per share, resulting in proceeds of $12,690. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.6K
0% 3M change
0% 12M change
Total Value Held $525,809

Sriram Ryali Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 14 2022
SELL
Open market or private sale
$12,690 $5.6 p/Share
2,266 Reduced 5.17%
41,566 Common Stock
Mar 11 2022
BUY
Grant, award, or other acquisition
-
24,000 Added 35.38%
43,832 Common Stock
Mar 12 2021
BUY
Grant, award, or other acquisition
-
16,250 Added 47.24%
18,152 Common Stock

Also insider at

CDXS
CODEXIS, INC. Healthcare
Chief Financial Officer
SR

Sriram Ryali

Chief Financial Officer
Palo Alto, CA

Track Institutional and Insider Activities on EIGR

Follow Eiger BioPharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EIGR shares.

Notify only if

Insider Trading

Get notified when an Eiger Bio Pharmaceuticals, Inc. insider buys or sells EIGR shares.

Notify only if

News

Receive news related to Eiger BioPharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EIGR